Samir M. Mazharuddin

Samir Mazharuddin practices at Texas Oncology PA in Humble, Texas.

Samir Mazharuddin's NPI, 1922442995, was assigned on April 22, 2013. Samir Mazharuddin graduated from Texas A&M College of Medicine - Bryan in 2013. Samir Mazharuddin's Texas license number on file is Q0975.

Samir Mazharuddin's primary practice is Texas Oncology PA, at 18980 N Memorial Dr, Humble, TX 77338 in Harris County. The practice phone is (972) 997-8000.

Samir Mazharuddin's primary practice is Texas Oncology PA in Humble, Texas. Samir Mazharuddin is also affiliated with Memorial Hermann Northeast Hospital. The medical group on file is Texas Oncology. Dmand AI also links Samir Mazharuddin to 2 more hospitals, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Samir Mazharuddin practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Samir Mazharuddin's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Samir Mazharuddin is board certified in hematology by the American Board of Internal Medicine. Samir Mazharuddin has a license on file in Texas.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, lung cancer, lymphoma, multiple myeloma and purpura and thrombocytopenia among the conditions Samir Mazharuddin treats.

CMS data shows 35,783 Medicare services from Samir Mazharuddin across 27 procedure codes in 2024, for 301 Medicare patients. Medicare paid $517,175 for them.

CMS counts 301 Medicare patients who saw Samir Mazharuddin in 2024. The largest group is 65 to 74, with 129 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Samir Mazharuddin's median patient age at 68, with 62% women.

In 2024, Samir Mazharuddin wrote 1,918 Medicare Part D claims for 292 patients. 82% of them were for generic drugs. CMS names the drug for 1,577 of them, across 56 drugs with 11 or more claims each, at $2,523,504 in total drug cost. In 2023, CMS named 784 claims across 29 drugs.

Samir Mazharuddin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Samir Mazharuddin as offering telehealth.

Dmand AI links 6 papers to Samir Mazharuddin, published from 2017 to 2019. 2019 was the busiest year, with 2. Samir Mazharuddin has published most often in Proc (Bayl Univ Med Cent). Samir Mazharuddin's most frequent co-authors are Eric Samuel Nadler, MD, Azaan Ramani, DO and Barry Cooper, MD.

CMS Open Payments shows 422 general payments to Samir Mazharuddin from 65 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 54% of the total. AstraZeneca Pharmaceuticals LP paid the most, $8,118.

Samir Mazharuddin graduated from Texas A&M College of Medicine - Bryan in 2013.

Samir Mazharuddin is in network with 22 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.